Related Experiment Video

Updated: Aug 25, 2026

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug
07:50

An In vitro System to Gauge the Thrombolytic Efficacy of Histotripsy and a Lytic Drug

Published on: June 4, 2021

Venous Thrombolysis: Current Perspectives

Jay Menon1, Mahmoud M. Salman, George Hamilton Md

  • 1University Department of Surgery, Royal Free Hospital, Royal Free and University College Medical School, UCL, Pond Street, London NW3 2QG, UK. G.hamilton@rfc.ucl.ac.uk

Current Treatment Options in Cardiovascular Medicine
|April 7, 2004
PubMed

Insights

Venous thromboembolism (VTE) is a common cardiovascular disease. While anticoagulation is standard, new thrombolytic therapies show promise for specific patient groups, though their role is still being explored.

Area of Science:

  • Cardiovascular Medicine
  • Hematology

Background:

  • Venous thromboembolism (VTE) is a prevalent condition impacting hospital and community patients.
  • VTE is the third leading cause of cardiovascular disease, following ischemic heart disease and stroke.
  • It significantly contributes to prolonged hospital stays, morbidity, and mortality.

Purpose of the Study:

  • To review the current understanding and emerging roles of thrombolysis in treating venous thrombosis.
  • To identify patient populations that may benefit from primary thrombolytic therapy.

Main Methods:

  • Literature review of traditional treatments and novel thrombolytic approaches for venous thrombosis.
  • Analysis of reported outcomes and challenges associated with systemic and catheter-directed thrombolysis.

Main Results:

  • Anticoagulation with heparin and warfarin remains the traditional treatment for venous thrombosis.
  • Thrombolytic therapy, including catheter-directed methods, shows promising results.
  • Systemic thrombolysis carries risks such as catheter fragmentation.

Conclusions:

  • The precise role of thrombolysis in venous thrombosis management is still under investigation.
  • Identifying specific patient groups for primary thrombolytic treatment is an ongoing area of research.
  • Emerging data suggest thrombolysis may offer a valuable alternative or adjunct treatment in select VTE cases.

More Related Videos

Prehospital Thrombolysis: A Manual from Berlin05:52

Prehospital Thrombolysis: A Manual from Berlin

Published on: November 26, 2013

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis I: Introduction01:30

Venous Thrombosis I: Introduction

Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...
Venous Thrombosis IV: Nursing Management01:30

Venous Thrombosis IV: Nursing Management

Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies01:20

Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies

The key difference between Superficial Vein Thrombosis (SVT) and Deep Vein Thrombosis (DVT) lies in their location and severity.Clinical ManifestationsSVT typically presents with localized pain, tenderness, and redness along the course of a superficial vein, often accompanied by a palpable, cord-like structure under the skin. This condition is usually less dangerous than DVT but can be uncomfortable and may lead to complications such as cellulitis or, rarely, a clot extension into the deep...
Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...